Your browser doesn't support javascript.
loading
Metabolomic and transcriptomic analyses provide insights into variations in flavonoids contents between two Artemisia cultivars.
Qiao, Yuchen; Wu, Liqin; Yang, Suling; Wang, Qing; Gu, Haike; Wei, Liqin; Liu, Guijun; Zhou, Sijing; Wang, Ping; Song, Meifang.
Afiliação
  • Qiao Y; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Wu L; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Yang S; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Wang Q; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Gu H; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Wei L; Beijing Science and Technology Innovation Promotion Center, Beijing, China.
  • Liu G; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Zhou S; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Wang P; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China.
  • Song M; Institute of Radiation Technology, Beijing Academy of Science and Technology, Beijing, China. songmeifang@brc.ac.cn.
BMC Plant Biol ; 23(1): 288, 2023 May 30.
Article em En | MEDLINE | ID: mdl-37254042
BACKGROUND: Plants in the genus Artemisia are rich in active ingredients and specialized metabolites. Many of these compounds, especially flavonoids, have potential medicinal and nutritional applications, and are of growing interest to scientists due to their wide range of pharmacological and biological activities. Artemisia cultivars are commonly used as raw materials for medicine, food, and moxibustion in China. However, most of the metabolites produced by Artemisia species have not been identified, and few studies have addressed differences in active compounds between species and cultivars. RESULTS: We here investigated two Artemisia cultivars, 'Nanyangshiyong' (NYSY) and 'Nanyangyaoyong' (NYYY), which are commonly used in foods and moxibustion, respectively. NYSY and NYYY were confirmed to be Artemisia argyi cultivars. Total flavonoids contents and antioxidant activities were higher in NYYY than in NYSY. A total of 882 metabolites were identified in the samples; most of the potentially medicinally active compounds, especially flavonoids (e.g., flavone, flavonol, isoflavone, and anthocyanin), were up-regulated in NYYY compared to NYSY. Furthermore, most of the genes related to flavonoids biosynthesis were up-regulated in NYYY. Correlation analysis was used to identify putative members of transcription factor families that may regulate genes encoding key flavonoids biosynthesis enzymes. CONCLUSIONS: We found that the antioxidant activities and flavonoids contents significantly varied between two Artemisia cultivars of the same species. We also uncovered metabolomic and transcriptomic evidence of the molecular phenomena underlying those differences in flavonoids contents between the two Artemisia cultivars. This study provides a wealth of data for future utilization and improvements of Artemisia cultivars, and highlights a need to study the specific metabolite profiles of plants that are used in foods and medicines.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artemisia Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artemisia Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article